Literature DB >> 26136831

Cost-effectiveness Assessment of Cardiac Interventions: Determining a Socially Acceptable Cost Threshold.

Chete M Eze-Nliam1, Zugui Zhang1, Sandra A Weiss1, William S Weintraub1.   

Abstract

Health care is a vital good for which there is an infinite demand. However, societal resources are finite and need to be distributed efficiently to avoid waste. Thus, the relative value of an intervention - cost compared to its effectiveness- needs to be taken into consideration when deciding which interventions to adopt. Cost-effectiveness analysis provides the crucial information which guides these decisions. As the field of medicine and indeed cardiology move forward with innovations which are effective but often expensive, it becomes imperative to employ these cost-effectiveness analytic tools, not with the intention of denying vital health services but to ascertain what the society willing to pay for.

Entities:  

Keywords:  Bypass surgery; clinical trials; cost-effectiveness; percutaneous coronary intervention; transcatheter valve therapy

Year:  2014        PMID: 26136831      PMCID: PMC4484870          DOI: 10.2217/ica.13.81

Source DB:  PubMed          Journal:  Interv Cardiol (Lond)        ISSN: 1755-5302


  28 in total

1.  Legislating against use of cost-effectiveness information.

Authors:  Peter J Neumann; Milton C Weinstein
Journal:  N Engl J Med       Date:  2010-10-14       Impact factor: 91.245

2.  A tale of two countries: costs and financial incentives for provisional stenting during percutaneous coronary intervention in France and the United States.

Authors:  I Durand-Zaleski; P Dupouy; D P Coste Carrié; A Furber; S Bastuji-Garin; P G Steg; J-L Dubois-Randé; M Kern; A Lafont
Journal:  Eur J Health Econ       Date:  2002

Review 3.  Cost-effectiveness of healthcare-based interventions aimed at improving physical activity.

Authors:  Lars A Hagberg; Lars Lindholm
Journal:  Scand J Public Health       Date:  2006       Impact factor: 3.021

4.  Cost effectiveness of community-based physical activity interventions.

Authors:  Larissa Roux; Michael Pratt; Tammy O Tengs; Michelle M Yore; Teri L Yanagawa; Jill Van Den Bos; Candace Rutt; Ross C Brownson; Kenneth E Powell; Gregory Heath; Harold W Kohl; Steven Teutsch; John Cawley; I-Min Lee; Linda West; David M Buchner
Journal:  Am J Prev Med       Date:  2008-12       Impact factor: 5.043

5.  The limits of cost-effectiveness analysis.

Authors:  William S Weintraub; David J Cohen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-01

6.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

7.  Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).

Authors:  Matthew R Reynolds; Elizabeth A Magnuson; Kaijun Wang; Vinod H Thourani; Mathew Williams; Alan Zajarias; Charanjit S Rihal; David L Brown; Craig R Smith; Martin B Leon; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2012-07-18       Impact factor: 24.094

8.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

9.  A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.

Authors:  Thomas Land; Nancy A Rigotti; Douglas E Levy; Mark Paskowsky; Donna Warner; Jo-Ann Kwass; Leann Wetherell; Lois Keithly
Journal:  PLoS Med       Date:  2010-12-07       Impact factor: 11.069

10.  Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation.

Authors:  Elisabeth Fenwick; Deborah A Marshall; Adrian R Levy; Graham Nichol
Journal:  BMC Health Serv Res       Date:  2006-04-19       Impact factor: 2.655

View more
  2 in total

1.  Changing the Health Behavior of Patients With Cardiovascular Disease Through an Electronic Health Intervention in Three Different Countries: Cost-Effectiveness Study in the Do Cardiac Health: Advanced New Generation Ecosystem (Do CHANGE) 2 Randomized Controlled Trial.

Authors:  Jordi Piera-Jiménez; Marjolein Winters; Eva Broers; Damià Valero-Bover; Mirela Habibovic; Jos W M G Widdershoven; Frans Folkvord; Francisco Lupiáñez-Villanueva
Journal:  J Med Internet Res       Date:  2020-07-28       Impact factor: 5.428

2.  Propitious temporal changes in clinical outcomes after transcatheter compared to surgical aortic valve replacement; a meta-analysis of over 65,000 patients.

Authors:  Ankur Panchal; Andreas Kyvernitakis; Geetha Rayarao; Mark Doyle; Robert W W Biederman
Journal:  J Cardiothorac Surg       Date:  2021-10-20       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.